This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dieterich, C.
Right arrow Articles by Corthésy-Theulaz, I. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dieterich, C.
Right arrow Articles by Corthésy-Theulaz, I. E.

 Previous Article  |  Next Article 

Infection and Immunity, November 1999, p. 6206-6209, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Urease-Based Mucosal Immunization against Helicobacter heilmannii Infection Induces Corpus Atrophy in Mice

Christine Dieterich,1 Hanifa Bouzourène,2 André L. Blum,1 and Irène E. Corthésy-Theulaz1,*

Division of Gastroenterology, Centre Hospitalier Universitaire Vaudois,1 and Pathology Institute, Lausanne University,2 Lausanne, Switzerland

Received 22 July 1999/Accepted 24 August 1999

Mucosal immunization with Helicobacter heilmannii urease B or Helicobacter pylori urease, given nasally with cholera toxin, protects BALB/c mice against H. heilmannii infection and significantly reduces a preexisting infection. However, immunization aggravates gastric corpus atrophy. Our results underline the necessity of defining immunization regimens that do not enhance mucosal damage.


* Corresponding author. Mailing address: Division of Gastroenterology, Department of Internal Medicine, CHUV-BH19N.624, CH-1011 Lausanne, Switzerland. Phone: 41 21 314 06 85. Fax: 41 21 314 06 84. E-mail: Irene.Corthesy{at}CHUV.hospvd.CH.


Infection and Immunity, November 1999, p. 6206-6209, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Kotloff, K. L., Sztein, M. B., Wasserman, S. S., Losonsky, G. A., DiLorenzo, S. C., Walker, R. I. (2001). Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection. Infect. Immun. 69: 3581-3590 [Abstract] [Full Text]  
  • Eaton, K. A., Mefford, M. E. (2001). Cure of Helicobacter pylori Infection and Resolution of Gastritis by Adoptive Transfer of Splenocytes in Mice. Infect. Immun. 69: 1025-1031 [Abstract] [Full Text]